Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor

BACKGROUND: Donor-derived malignancy is a rare complication in patients who undergo organ transplant. Approaches to treatment have largely been individualized based on clinical circumstances given the lack of evidence-based guidelines, with therapeutic options ranging from discontinuation of immunos...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Case Rep Urol
Autors principals: Chiang, Ryan S., Connor, Ashton A., Inman, Brant A., Foo, Wen-Chi, Howell, David N., Madden, John F., Ellis, Matthew J., Rege, Aparna S., Harrison, Michael R.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2020
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7773455/
https://ncbi.nlm.nih.gov/pubmed/33425425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8881841
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars